Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Danaher Corporation (DHR : NYSE)
 
 • Company Description   
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.

Number of Employees: 63,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $204.85 Daily Weekly Monthly
20 Day Moving Average: 3,291,909 shares
Shares Outstanding: 715.67 (millions)
Market Capitalization: $146,604.91 (millions)
Beta: 0.77
52 Week High: $281.70
52 Week Low: $171.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.08% -2.53%
12 Week 9.65% -7.47%
Year To Date -10.76% -16.15%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2200 PENNSYLVANIA AVENUE. N.W SUITE 800W
-
WASHINGTON,DC 20037
USA		 ph: 202-828-0850
fax: 202-828-0860		 investor.relations@danaher.com http://www.danaher.com
 
 • General Corporate Information   
Officers
Rainer M. Blair - Chief Executive Officer;President
Steven M. Rales - Chairman of the Board
Mitchell P. Rales - Chairman of the Executive Committee
Matthew R. McGrew - Chief Financial Officer;Executive Vice President
Christopher M. Bouda - Vice President and Chief Accounting Officer

Peer Information
Danaher Corporation (CHCR)
Danaher Corporation (ESRX)
Danaher Corporation (MYDP)
Danaher Corporation (COR)
Danaher Corporation (GBCS)
Danaher Corporation (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 235851102
SIC: 3823
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/22/25
Share - Related Items
Shares Outstanding: 715.67
Most Recent Split Date: 6.00 (2.00:1)
Beta: 0.77
Market Capitalization: $146,604.91 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.62%
Current Fiscal Quarter EPS Consensus Estimate: $1.80 Indicated Annual Dividend: $1.28
Current Fiscal Year EPS Consensus Estimate: $7.70 Payout Ratio: 0.17
Number of Estimates in the Fiscal Year Consensus: 11.00 Change In Payout Ratio: 0.06
Estmated Long-Term EPS Growth Rate: 9.25% Last Dividend Paid: 06/27/2025 - $0.32
Next EPS Report Date: 07/22/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 26.61
Trailing 12 Months: 27.50
PEG Ratio: 2.88
Price Ratios
Price/Book: 2.88
Price/Cash Flow: 18.75
Price / Sales: 6.15
EPS Growth
vs. Year Ago Period: -2.08%
vs. Previous Quarter: -12.15%
Sales Growth
vs. Year Ago Period: -0.95%
vs. Previous Quarter: -12.19%
ROE
06/30/25 - -
03/31/25 - 10.80
12/31/24 - 10.82
ROA
06/30/25 - -
03/31/25 - 6.89
12/31/24 - 6.90
Current Ratio
06/30/25 - -
03/31/25 - 1.43
12/31/24 - 1.40
Quick Ratio
06/30/25 - -
03/31/25 - 1.05
12/31/24 - 1.05
Operating Margin
06/30/25 - -
03/31/25 - 22.85
12/31/24 - 23.14
Net Margin
06/30/25 - -
03/31/25 - 15.81
12/31/24 - 16.33
Pre-Tax Margin
06/30/25 - -
03/31/25 - 18.91
12/31/24 - 19.46
Book Value
06/30/25 - -
03/31/25 - 71.06
12/31/24 - 68.60
Inventory Turnover
06/30/25 - -
03/31/25 - 3.76
12/31/24 - 3.75
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.31
12/31/24 - 0.31
Debt-to-Capital
06/30/25 - -
03/31/25 - 23.90
12/31/24 - 23.83
 

Powered by Zacks Investment Research ©